Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS’ Blum Assumes New High-Level Duties As ACA Implementation Proceeds

Executive Summary

CMS Deputy Administrator Jonathan Blum is taking on some of the responsibilities previously handled by Acting Administrator Marilyn Tavenner as the agency faces deadlines in implementing key elements of the health reform law.

You may also be interested in...



Unfinished Business For Blum’s Successor At CMS Includes Reworking Part D Protected Classes

CMS’ Medicare chief Jonathan Blum will leave in mid-May and be succeeded by Center for Medicare and Medicaid Innovation Deputy Director Sean Cavanaugh. Other changes within the Medicare organization have also been announced.

CMS Administrator-Nominee Tavenner Would Bring Leadership Continuity As ACA Implementation Continues

With the selection of Centers for Medicare and Medicaid Services Principal Deputy Administrator Marilyn Tavenner as Don Berwick’s successor, the Obama administration appears to be seeking leadership continuity with a candidate that has a good chance of gaining Senate confirmation.

GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows

A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS054573

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel